Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction

References

• Iwano M, Neilson EG. Mechanism of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens. 2004;13:279–284
   PubMed Web of Science ®Google Scholar
• Sharma AK, Mauer SM, Kim Y, Michael AF. Interstitial fibrosis in obstructive nephropathy. Kidney Int. 1993;44:774–788
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Duffield JS. Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol. 2010;21:1247–1253
   PubMed Web of Science ®Google Scholar
• Chien CT, Lee PH, Chen CF, Ma MC, Lai MK, Hsu SM. De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. J Am Soc Nephrol. 2001;12:973–982
   PubMed Web of Science ®Google Scholar
• Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006;17:1503–1520
   PubMed Web of Science ®Google Scholar
• Qi W, Twigg S, Chen X, et al. Integrated actions of transforming growth factor-beta 1 and connective tissue growth factor in renal fibrosis. Am J Physiol Renal Physiol. 2005;288:F800–F809
   PubMed Web of Science ®Google Scholar
• Wang W, Koka V, Lan HY. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology. 2005;10:48–56
   PubMed Web of Science ®Google Scholar
• Soleas GJ, Diamandis EP, Goldberg DM. Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal. 1997;11:287–313
   PubMed Web of Science ®Google Scholar
• Saiko P, Szakmary A, Jaeger W, Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res. 2008;658:68–94
   PubMed Web of Science ®Google Scholar
• Chan AY, Dolinsky VW, Soltys CL, et al. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J Biol Chem. 2008;283:24194–24201
   PubMed Web of Science ®Google Scholar
• Zhao XY, Li GY, Liu Y, et al. Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Br J Pharmacol. 2008;154:105–113
   PubMed Web of Science ®Google Scholar
• Giovannini L, Migliori M, Longoni BM, et al. Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharm. 2001;37:262–270
   PubMed Web of Science ®Google Scholar
• Sener G, Tugtepe H, Yuksel M, Cetinel S, Gedik N, Yegen BC. Resveratrol improves ischemia/reperfusion-induced oxidative renal injury in rats. Arch Med Res. 2006;37:822–829
   PubMed Web of Science ®Google Scholar
• Kitada M, Kume S, Imaizumi N, Koya D. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes. 2011;60:634–643
   PubMed Web of Science ®Google Scholar
• Wu MJ, Wen MC, Chiu YT, Chiou YY, Shu KH, Tang MJ. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int. 2006;69:2029–2036
   PubMed Web of Science ®Google Scholar
• Yeh CH, Chiang HS, Lai TY, Chien CT. Unilateral ureteral obstruction evokes renal tubular apoptosis via the enhanced oxidative stress and endoplasmic reticulum stress in the rat. Neurourol Urodyn. 2011;30:472–479
   PubMed Web of Science ®Google Scholar
• Kim J, Kim DS, Park MJ, et al. Omi/HtrA2 protease is associated with tubular cell apoptosis and fibrosis induced by unilateral ureteral obstruction. Am J Physiol Renal Physiol. 2010;298:F1332–F1340
   Google Scholar
• Kim MY, Lim JH, Youn HH, et al. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1a axia in db/db mice. Diabetologia. 2013;56:204–217
   PubMed Web of Science ®Google Scholar
• Nagai Y, Yao L, Kobori H, et al. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol. 2005;16:703–711
   PubMedGoogle Scholar
• Remuzzi G, Zoja C, Gagliardini E, Corna D, Abbate M, Benigni A. Combining an antiproteinuric approach with mycophenolate mofetilfully suppresses progressive nephropathy of experimental animals. J Am Soc Nephrol. 1999;10:1542–1549
   PubMed Web of Science ®Google Scholar
• Li J, Qu X, Ricardo SD, Bertram JF, Nikolic-Paterson DJ. Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3. Am J Pathol. 2010;177:1065–1071
   PubMed Web of Science ®Google Scholar
• Moriyama T, Kawada N, Akagi Y, et al. TCV-116 inhibits interstitial fibrosis and HSP47 mRNA in rat obstructive nephrology. Kidney Int Suppl. 1997;63:S232–S235
   Google Scholar
• Modi KS, Morrissey J, Shah SV, Schreiner GF, Klahr S. Effects of probucol on renal function in rats with bilateral ureteral obstruction. Kidney Int. 1990;38:843–850
   PubMed Web of Science ®Google Scholar
• Sunami R, Sugiyama H, Wang DH, et al. Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Am J Physiol Renal Physiol. 2004;286:F1030–F1038
   PubMed Web of Science ®Google Scholar
• Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis: the role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int Suppl. 2003;87:S105–S112
   Google Scholar
• Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev. 2000;14:627–644
   PubMed Web of Science ®Google Scholar
• Shimizu T, Kuroda T, Hata S, Fukagawa M, Margolin SB, Kurokawa K. Pirfenidone improves renal function and fibrosis in the post-obstructed kidney. Kidney Int. 1998;54:99–109
   PubMed Web of Science ®Google Scholar
• He W, Wang Y, Zhang MZ, et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest. 2010;120:1056–1068
   PubMed Web of Science ®Google Scholar
• Meldrum KK, Metcalfe P, Leslie JA, Misseri R, Hile KL, Meldrum DR. TNF-alpha neutralization decreases nuclear factor-kappa B activation and apoptosis during renal obstruction. J Surg Res. 2006;131:182–188
   Web of Science ®Google Scholar
• Shappell SB, Mendoza LH, Gurpinar T, Smith CW, Suki WN, Truong LD. Expression of adhesion molecules in kidney with experimental chronic obstructive uropathy: the pathogenic role of ICAM-1 and VCAM-1. Nephron. 2000;85:156–166
   PubMedGoogle Scholar